^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
valecobulin (CKD-516)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chong Kun Dang
Drug class:
Tubulin polymerization inhibitor, Vascular disrupting agent
Related drugs:
Phase 1
National OncoVenture
Unknown status
Last update posted :
08/14/2015
Initiation :
12/01/2014
Primary completion :
07/01/2016
Completion :
07/01/2016
VEGFA • CXCL12 • CSF2
|
valecobulin (CKD-516)
Share
